Bethany Mancilla serves as the Chief Business Officer at Capsida overseeing business operations. She has more than 25 years of biotechnology experience in business development, corporate strategy, and financing across large and small biopharmaceutical companies. Ms. Mancilla began her career commercializing innovations and establishing startup companies out of Baylor College of Medicine prior to transitioning into emerging biotechnology companies – including Gene Logic and Micromet – where she spearheaded several major pharmaceutical collaborations with companies including Pfizer, Roche, Lilly and Amgen. Following the acquisition of Micromet by Amgen, Ms. Mancilla assumed escalating roles and responsibilities, becoming the Vice President of Business Development at Amgen, overseeing a team of 20 responsible for licensing, collaborations, equity investments, joint ventures, and mergers and acquisitions. Most recently, Ms. Mancilla served as Vice President of Corporate Development at Kite Pharma and as Chief Business Officer of Cue Biopharma where she oversaw a range of business operations including business development, corporate strategy and corporate communications.

Ms. Mancilla holds a B.A. from the University of Colorado and an M.B.A. from the University of Houston.